October 24, 1987 |
Looking back, Jeff Mullican now believes it began during the first tentative stirring of a New England spring. Six months ago, at a time when the earth around him was beginning its annual process of renewal, and his own health, all things considered, was remarkably good, Mullican began to feel that he had turned a dreadful corner.
January 23, 1997 |
A leading AIDS researcher on Wednesday raised the provocative notion that powerful drug combinations could eradicate the AIDS virus from the body after three years. Dr. David Ho, the highly respected director of the Aaron Diamond AIDS Research Center in New York, said a mathematical model developed by one of his collaborators projected the three-year period for eliminating the virus from an infected individual receiving a successful drug-combination treatment.
August 21, 1990 |
The AIDS epidemic has created a quiet revolution in the way experimental drugs and life-threatening diseases are studied in children. "The tradition until recently has been to 'protect' children from experimental therapy," said Dr. Philip Pizzo, chief of pediatrics at the National Cancer Institute. "The general requirement was that one must complete Phase 1 (safety) testing in adults before beginning with children. When AIDS came along, it required a change of philosophy."
October 9, 1991 |
Federal health officials are expected to announce today that they have approved the AIDS antiviral drug DDI, making it the second such drug to be licensed since the 1987 approval of AZT. DDI--also known as dideoxyinosine and didanosine--would provide an alternative treatment for the thousands of AIDS patients who cannot medically tolerate AZT.
July 23, 1987 |
Researchers said Wednesday they have identified a type of cell in blood that seeks out the AIDS virus and destroys it, a discovery that may explain why some infected people go on to develop the disease while others do not. The newly discovered killer cells, called cytotoxic T lymphocytes, may also aid in the development of a vaccine against the deadly disease, said doctors at Massachusetts General Hospital who made the discovery.
January 24, 1997 |
AIDS-related hospitalizations have plummeted since potent combinations of three drugs have become the standard of care, officials with several clinics--including one from Los Angeles--reported Thursday. But concerns have surfaced that use of the treatment is being stymied by gaps in insurance coverage. The average annual cost of using the drugs is estimated at $15,000.